Everpure Co-Founder & Director John Colgrove Files Form 144 to Sell $10.4M in Stock

Executive Summary

On September 21, 2026, John Colgrove, Director and Officer of Everpure, Inc. (CIK: 0001474432), filed a Form 144 notice disclosing the intended sale of 100,000 shares of common stock through The Colgrove Family Charitable Remainder Trust U/A DTD 04/05/2024. The total estimated market value of the proposed disposition is $10,414,000.00, representing an implied share price of $104.14.

Transaction & Plan Details

• Security: Common Stock
• Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
• Approximate Sale Date: September 21, 2026
• Shares Outstanding: 333,227,251 (proposed sale represents ~0.03% of outstanding shares)
• Rule 10b5-1 Plan Adoption Date: January 8, 2026
• Acquisition Origin: Founder shares acquired from the issuer on October 10, 2009

Historical Context & Recent Selling Pattern

Over the past three months, entities affiliated with John Colgrove (including the Charitable Remainder Trust, The EEC Trust, and The RWC Trust) have engaged in routine selling activity under pre-established Rule 10b5-1 trading plans:

• Multiple dispositions occurred across July, August, and September 2026, totaling several hundred thousand shares.
• Because this proposed transaction follows an established Rule 10b5-1 plan adopted in January 2026 and represents founder equity diversification, the market significance is classified as Medium.